رجوع

Watch Compare

NEPHROS INC

جودة البيانات: 100%

NEPH

Nasdaq Manufacturing Measuring & Analyzing Instruments

KWD 2.92

▲ KWD 0.01 (0.17%)

القيمة السوقية: 31.03 M

السعر

KWD 2.92

القيمة السوقية

31.03 M

نطاق اليوم

KWD 2.81 — KWD 2.95

نطاق 52 أسبوعًا

KWD 1.64 — KWD 6.42

حجم التداول

3,804

فتح KWD 2.82

متوسط 50 يوم / 200 يوم

KWD 3.72

21.57% below

متوسط 50 يوم / 200 يوم

KWD 4.32

32.52% below

Quick Summary

النقاط الرئيسية

Revenue grew 15.92% annually over 5 years — strong growth

Earnings grew 1513.51% over the past year

ROE of 12.18% — decent returns on equity

Generating 1.59 M in free cash flow

Revenue growth is accelerating — 1Y growth exceeds 5Y average by 16.75%

Cash machine — converts 133.17% of earnings into free cash flow

النمو

Revenue Growth (5Y)

15.92%

أعلى من متوسط القطاع (1.82%)

Revenue (1Y)32.67%

Earnings (1Y)1513.51%

FCF Growth (3Y)45.41%

الجودة

Return on Equity

12.18%

أعلى من متوسط القطاع (-53.41%)

ROIC10.68%

Net Margin6.35%

Op. Margin6.10%

الأمان

Debt / Equity

N/A

Current Ratio4.34

Interest Coverage1146.00

التقييم

PE (TTM)

25.99

أعلى من متوسط القطاع (-1.48)

P/B Ratio3.10

EV/EBITDA20.11

Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)

المقياس	السهم	وسيط القطاع
P/E	26.0	-1.5
P/B	3.1	1.6
ROE %	12.2	-53.4
Net Margin %	6.4	-41.5
Rev Growth 5Y %	15.9	1.8
D/E	—	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	32.67%	Revenue Growth (3Y)	14.88%
Earnings Growth (1Y)	1513.51%	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	15.92%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	18.79 M	Net Income (TTM)	1.19 M
ROE	12.18%	ROA	9.37%
Gross Margin	61.87%	Operating Margin	6.10%
Net Margin	6.35%	Free Cash Flow (TTM)	1.59 M
ROIC	10.68%	FCF Growth (3Y)	45.41%
Safety
Debt / Equity	N/A	Current Ratio	4.34
Interest Coverage	1146.00	Asset Turnover	1.47
Working Capital	8.24 M	Tangible Book Value	8.92 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	25.99	Forward P/E	N/A
P/B Ratio	3.10	P/S Ratio	1.65
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	20.11	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	5.12%
Market Cap	31.03 M	Enterprise Value	25.86 M
Per Share
EPS (Diluted TTM)	0.11	Revenue / Share	1.77
FCF / Share	0.15	OCF / Share	0.15
EPS CAGR (1Y)	1000.00%	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	0.29%	FCF Conversion	133.17%
SBC-Adj. FCF	1.31 M	Growth Momentum	16.75

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	18.79 M	14.16 M	14.24 M	9.98 M	10.40 M
Net Income	1.19 M	74,000.0	-1.58 M	-7.11 M	-3.87 M
EPS (Diluted)	0.11	0.01	-0.15	—	—
Gross Profit	11.63 M	8.72 M	8.41 M	4.73 M	5.74 M
Operating Income	1.15 M	6,000.0	-1.59 M	-4.34 M	-4.34 M
EBITDA	—	—	—	—	—
R&D Expenses	1.34 M	906,000.0	873,000.0	1.26 M	2.17 M
SG&A Expenses	9.00 M	7.68 M	8.91 M	7.59 M	7.71 M
D&A	140,000.0	135,000.0	214,000.0	218,000.0	202,000.0
Interest Expense	1,000.0	1,000.0	2,000.0	20,000.0	41,000.0
Income Tax	12,000.0	15,000.0	0.0	0.0	—

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	13.64 M	11.21 M	11.86 M	11.00 M	17.65 M
Total Liabilities	3.44 M	2.63 M	3.50 M	2.12 M	2.90 M
Shareholders' Equity	10.20 M	8.59 M	8.36 M	5.59 M	11.70 M
Total Debt	—	—	—	71,000.0	343,000.0
Cash & Equivalents	5.40 M	3.76 M	4.31 M	3.63 M	6.97 M
Current Assets	11.22 M	8.30 M	8.41 M	8.26 M	13.63 M
Current Liabilities	2.77 M	1.56 M	2.11 M	1.41 M	2.39 M